PUBLIC COMPANY
saveOrphAI Therapeutics Inc
updated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
3
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis
- phase2A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
- phase1A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma
- phase1A Study of LAM-003 in Patients With Acute Myeloid Leukemia
- phase2A Study of LAM-002A for the Prevention of Progression of COVID-19
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that